AlanMyerTennenbergMDMPH

Chief Medical Officer Global Public Health, Johnson & Johnson

Dr. Tennenberg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

New York Presbyterian Hospital (Cornell Campus)Residency, Public Health and General Preventive Medicine, 1995 - 1997
Mailman School of Publc HealthMPH, 1995 - 1997
New York Presbyterian Hospital (Cornell Campus)Fellowship, Infectious Disease, 1994 - 1995
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1991 - 1994
Perelman School of Medicine at the University of PennsylvaniaClass of 1991

PubMed

81 citations
Levofloxacin compared with imipenem/cilastatin followed by ciprofloxacin in adult patients with nosocomial pneumonia: A multicenter, prospective, randomized, open-labe...
Mike West, Bernard R. Boulanger, Charles Fogarty, Alan M. Tennenberg, Barbara A. Wiesinger
Clinical Therapeutics. 2003-02-01
24 citations
Levofloxacin for treatment of ventilator-associated pneumonia: a subgroup analysis from a randomized trial.
Andrew F. Shorr, Neringa Zadeikis, William L. Jackson, Anthony S. Ramage, Shu Chen Wu
Clinical Infectious Diseases. 2005-02-15
239 citations
High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm.
Lala M. Dunbar, Richard G. Wunderink, Michael P. Habib, Leon G. Smith, Alan M. Tennenberg
Clinical Infectious Diseases. 2003-09-15

Opinion Pieces Discuss Various Aspects of COVID-19 Pandemic, Response, Including Importance of Global Action on Climate Change, Impact on Economies, Global HungerJune 17th, 2020